Still River Systems Inc. raised $33 million from investors to speed development of its radiation therapy system.
The Littleton-based startup, which is developing a proton-beam radiotherapy therapy system it calls the Monarch250, plans to use the cash to expedite its development.
Investors ponying up for the latest round include new backer Venrock Associates and existing investors Caxton Health and Life Sciences and CHL Medical Partners.